open access

Vol 24, No 5 (2019)
Original research articles
Published online: 2019-09-01
Submitted: 2018-11-22
Get Citation

A closer look at the conventional Winston-Lutz test: Analysis in terms of dose

Juan-Francisco Calvo-Ortega, Sandra Moragues-Femenía, Coral Laosa-Bello, Sol San José-Maderuelo, Joan Casals-Farran
DOI: 10.1016/j.rpor.2019.07.003
·
Rep Pract Oncol Radiother 2019;24(5):421-427.

open access

Vol 24, No 5 (2019)
Original research articles
Published online: 2019-09-01
Submitted: 2018-11-22

Abstract

Aim

To investigate whether the target-isocenter deviations reported by a conventional Winston-Lutz (WL) test actually reflect the shifts of the measured prescription isodose line with respect to the target.

Background

A conventional WL test uses a metallic ball as a target that aims at several fields. But this test does not report information on the accuracy of the delivery in terms of dose.

Materials and methods

A conventional WL test using a metallic pointer as a target (Pointer-WL test) has been recreated in the Eclipse treatment planning system over an acrylic phantom containing a radiochromic film (Dose-WL test). After Dose-WL test delivery, the shift of the 80% prescription isodose line with respect to the target center (d80%-center) was measured using film dosimetry. The Pointer-WL and Dose-WL tests were performed in 10 different sessions. The isocenter deviation reported by the Pointer-WL test was compared to the d80%-center vector, according to the three patient's directions (Left–Right or LR; Anterior–Posterior or AP; and Superior–Inferior or SI).

Results

The deviations (mean±SD) found for the Dose-WL tests (LR: 0.5±0.4mm; AP: 0.5±0.4mm; SI: 0.6±0.2mm) were in most cases less than 1mm, and they were significantly smaller (all p<0.05) than the maximum deviations reported by the Pointer-WL tests (LR: 1.3±0.3mm; AP: 1.2±0.4mm; SI: 1.1±0.3mm).

Conclusions

The Dose-WL test described in this study allows estimating the spatial accuracy of the prescription isodose line.

Abstract

Aim

To investigate whether the target-isocenter deviations reported by a conventional Winston-Lutz (WL) test actually reflect the shifts of the measured prescription isodose line with respect to the target.

Background

A conventional WL test uses a metallic ball as a target that aims at several fields. But this test does not report information on the accuracy of the delivery in terms of dose.

Materials and methods

A conventional WL test using a metallic pointer as a target (Pointer-WL test) has been recreated in the Eclipse treatment planning system over an acrylic phantom containing a radiochromic film (Dose-WL test). After Dose-WL test delivery, the shift of the 80% prescription isodose line with respect to the target center (d80%-center) was measured using film dosimetry. The Pointer-WL and Dose-WL tests were performed in 10 different sessions. The isocenter deviation reported by the Pointer-WL test was compared to the d80%-center vector, according to the three patient's directions (Left–Right or LR; Anterior–Posterior or AP; and Superior–Inferior or SI).

Results

The deviations (mean±SD) found for the Dose-WL tests (LR: 0.5±0.4mm; AP: 0.5±0.4mm; SI: 0.6±0.2mm) were in most cases less than 1mm, and they were significantly smaller (all p<0.05) than the maximum deviations reported by the Pointer-WL tests (LR: 1.3±0.3mm; AP: 1.2±0.4mm; SI: 1.1±0.3mm).

Conclusions

The Dose-WL test described in this study allows estimating the spatial accuracy of the prescription isodose line.

Get Citation

Keywords

Winston-Lutz; SRS; Radiochromic

About this article
Title

A closer look at the conventional Winston-Lutz test: Analysis in terms of dose

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 24, No 5 (2019)

Pages

421-427

Published online

2019-09-01

DOI

10.1016/j.rpor.2019.07.003

Bibliographic record

Rep Pract Oncol Radiother 2019;24(5):421-427.

Keywords

Winston-Lutz
SRS
Radiochromic

Authors

Juan-Francisco Calvo-Ortega
Sandra Moragues-Femenía
Coral Laosa-Bello
Sol San José-Maderuelo
Joan Casals-Farran

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl